Breaking News - The Fly

Open Search

ALGS

Aligos Therapeutics

$

()

Aligos dosing initiated in Phase 2a HERALD study of ALG-055009, data due in Q4

ALGS

4/3/2024 - 08:31am

Aligos presents data at APASL 2024 from ALG-055009, ALG-000184 studies

ALGS

3/27/2024 - 08:13am

Aligos Therapeutics initiates Phase 2a HERALD study of ALG-055009

ALGS

3/18/2024 - 08:10am

Aligos Therapeutics to host conference call

ALGS

3/7/2024 - 15:45pm

Aligos Therapeutics to host conference call

ALGS

3/7/2024 - 04:55am

Aligos Therapeutics to host conference call

ALGS

3/7/2024 - 00:10am

Aligos Therapeutics enhances finance leadership team

ALGS

2/13/2024 - 08:16am

The biotech stocks to own in 2024, according to Piper Sandler

MDGL , CYTK , CBAY

…

1/2/2024 - 12:13pm

Aligos Therapeutics files to sell 168.73M shares of common stock for holders

ALGS

11/17/2023 - 16:40pm

Aligos Therapeutics presents clinical, nonclinical data at AASLD meeting

ALGS

11/13/2023 - 08:49am

Aligos Therapeutics presents data on ALG-000184 at AASLD Liver meeting 2023

ALGS

11/10/2023 - 08:11am

Aligos Therapeutics announces $92M private placement financing

ALGS

10/23/2023 - 08:18am

Aligos Therapeutics announces award of an $8.5M NIAID contract

ALGS

10/3/2023 - 07:36am

Aligos Therapeutics announces IND clearance for ALG-055009

ALGS

9/21/2023 - 07:32am

Aligos selects Stephen Harrison as principal investigator in ALG-055009 study

ALGS

7/19/2023 - 07:37am